Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 47 | $670,399 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Jan 2025 19:27 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 16 Jan 2025 | Sale | 3,554 | 0.58 | 2,061 | D |
| 17 Jan 2025 19:26 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | Director | 16 Jan 2025 | Sale | 8,637 | 0.58 | 5,009 | D |
| 17 Jan 2025 19:25 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 16 Jan 2025 | Sale | 8,048 | 0.58 | 4,668 | D |
| 17 Jan 2025 19:21 | MRSN | Mersana Therapeutics Inc | HUBER MARTIN H. JR. | President, CEO | 16 Jan 2025 | Sale | 4,514 | 0.58 | 2,618 | D |
| 17 Jan 2025 19:20 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 16 Jan 2025 | Sale | 8,470 | 0.58 | 4,913 | D |
| 17 Jan 2025 19:18 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 16 Jan 2025 | Sale | 5,096 | 0.58 | 2,956 | D |
| 17 Jan 2025 19:18 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 16 Jan 2025 | Sale | 5,939 | 0.58 | 3,445 | D |
| 16 Jan 2025 17:25 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | Director | 15 Jan 2025 | Sale | 6,191 | 0.63 | 3,900 | D |
| 16 Jan 2025 17:25 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 15 Jan 2025 | Sale | 1,791 | 0.63 | 1,128 | D |
| 16 Jan 2025 17:24 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 15 Jan 2025 | Sale | 1,794 | 0.63 | 1,130 | D |
| 16 Jan 2025 17:23 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 15 Jan 2025 | Sale | 2,331 | 0.63 | 1,469 | D |
| 16 Jan 2025 17:23 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 15 Jan 2025 | Sale | 952 | 0.63 | 600 | D |
| 15 Jan 2025 21:20 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | Director | 14 Jan 2025 | Sale | 11,534 | 0.66 | 7,612 | D |
| 15 Jan 2025 21:19 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 14 Jan 2025 | Sale | 1,007 | 0.66 | 665 | D |
| 15 Jan 2025 21:18 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 14 Jan 2025 | Sale | 3,483 | 0.66 | 2,299 | D |
| 15 Jan 2025 21:17 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 14 Jan 2025 | Sale | 3,713 | 0.66 | 2,451 | D |
| 15 Jan 2025 21:17 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 14 Jan 2025 | Sale | 3,330 | 0.66 | 2,198 | D |
| 15 Jan 2025 21:16 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 14 Jan 2025 | Sale | 3,253 | 0.66 | 2,147 | D |
| 29 Oct 2024 16:43 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 28 Oct 2024 | Sale | 1,884 | 1.9 | 3,580 | D |
| 07 Oct 2024 17:48 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 02 Oct 2024 | Sale | 8,089 | 2 | 16,178 | D |
| 07 Oct 2024 17:48 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 03 Oct 2024 | Sale | 5,598 | 1.96 | 10,972 | D |
| 07 Oct 2024 17:48 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 02 Oct 2024 | Sale | 8,089 | 2 | 16,178 | D |
| 07 Oct 2024 17:48 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 03 Oct 2024 | Sale | 5,598 | 1.96 | 10,972 | D |
| 07 Oct 2024 17:47 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 02 Oct 2024 | Sale | 8,089 | 2 | 16,178 | D |
| 07 Oct 2024 17:47 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 03 Oct 2024 | Sale | 5,598 | 1.96 | 10,972 | D |
| 07 Oct 2024 17:47 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 02 Oct 2024 | Sale | 4,855 | 2 | 9,710 | D |
| 07 Oct 2024 17:47 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 03 Oct 2024 | Sale | 3,361 | 1.96 | 6,588 | D |
| 07 Oct 2024 17:46 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 02 Oct 2024 | Sale | 8,089 | 2 | 16,178 | D |
| 07 Oct 2024 17:46 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 03 Oct 2024 | Sale | 5,598 | 1.96 | 10,972 | D |
| 13 Sep 2024 17:08 | MRSN | Mersana Therapeutics Inc | HUBER MARTIN H. JR. | President, CEO | 12 Sep 2024 | Sale | 50,423 | 1.76 | 88,744 | D |
| 17 Jan 2024 17:21 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | Director | 16 Jan 2024 | Sale | 29,399 | 2.71 | 79,671 | D |
| 17 Jan 2024 17:21 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | SVP, Chief Manuf. Officer | 16 Jan 2024 | Sale | 3,357 | 2.71 | 9,097 | D |
| 17 Jan 2024 17:20 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 16 Jan 2024 | Sale | 5,025 | 2.71 | 13,618 | D |
| 17 Jan 2024 17:19 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 16 Jan 2024 | Sale | 10,409 | 2.71 | 28,208 | D |
| 17 Jan 2024 17:18 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 16 Jan 2024 | Sale | 4,381 | 2.71 | 11,873 | D |
| 17 Jan 2024 17:18 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 16 Jan 2024 | Sale | 9,327 | 2.71 | 25,276 | D |
| 17 Jan 2024 17:16 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 16 Jan 2024 | Sale | 3,431 | 2.71 | 9,298 | D |
| 27 Oct 2023 16:07 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 26 Oct 2023 | Sale | 1,912 | 1.13 | 2,161 | D |
| 18 Aug 2023 16:01 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | SVP, Chief Manuf. Officer | 17 Aug 2023 | Sale | 1,908 | 1.18 | 2,251 | D |
| 28 Apr 2023 16:15 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 27 Apr 2023 | Sale | 3,944 | 3.89 | 15,342 | D |
| 18 Jan 2023 20:29 | MRSN | Mersana Therapeutics Inc | YANG ARVIN | SVP, Chief Medical Officer | 17 Jan 2023 | Sale | 2,209 | 5.74 | 12,680 | D |
| 18 Jan 2023 20:24 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | President & CEO | 17 Jan 2023 | Sale | 17,346 | 5.74 | 99,566 | D |
| 18 Jan 2023 20:20 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Controller | 17 Jan 2023 | Sale | 3,575 | 5.74 | 20,520 | D |
| 18 Jan 2023 20:18 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | SVP, CMO | 17 Jan 2023 | Sale | 458 | 5.74 | 2,629 | D |
| 18 Jan 2023 20:14 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Off. | 17 Jan 2023 | Sale | 6,233 | 5.74 | 35,777 | D |
| 18 Jan 2023 20:12 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, Chief Financial Officer | 17 Jan 2023 | Sale | 5,131 | 5.74 | 29,452 | D |
| 18 Jan 2023 20:09 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 17 Jan 2023 | Sale | 782 | 5.74 | 4,489 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)